The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarkers predicting response to 5 immunotherapy arms in the neoadjuvant I-SPY2 trial for early-stage breast cancer (BC): Evaluation of immune subtyping in the response predictive subtypes (RPS).
 
Denise M. Wolf
No Relationships to Disclose
 
Christina Yau
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 63/314,065 (Inst); U.S. Provisional Application No. 63/341,579 (Inst)
 
Michael J. Campbell
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I)
Research Funding - Gilead Sciences (I)
Patents, Royalties, Other Intellectual Property - Royalties from a monoclonal antibody developed while at Stanford University.
Travel, Accommodations, Expenses - Gilead Sciences (I)
 
Annuska M. Glas
Employment - Agendia
 
Lorenza Mittempergher
Employment - Agendia
 
Midas M. Kuilman
No Relationships to Disclose
 
Andrei Barcaru
No Relationships to Disclose
 
Lamorna Brown Swigart
No Relationships to Disclose
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Cardinal Health; Fujifilm; GE Healthcare; Gilead Sciences; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; OBI Pharma; OncoSec; Sanofi; Seagen
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Amy Jo Chien
Honoraria - bioTheranostics; sanofi
Consulting or Advisory Role - Novartis; SeaGen
Research Funding - Amgen (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; OncoSec; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Rebecca Arielle Shatsky
Honoraria - AstraZeneca; Relevate Health; SOTERIA Precision Medicine; The Dedham Group
Consulting or Advisory Role - OncoSec; Puma Biotechnology; SOTERIA Precision Medicine; The Dedham Group
Speakers' Bureau - Gilead Sciences
Research Funding - Genentech (Inst); Merck (Inst); OBI Pharma (Inst); OncoSec (Inst); Oncternal Therapeutics (Inst); Phoenix Molecular Designs (Inst); QuantumLeap Health (Inst)
 
Claudine Isaacs
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Genentech/Roche; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Other Relationship - Side-Out Foundation
 
Jane Perlmutter
No Relationships to Disclose
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Laura van 't Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia